Medicinal Chemicals & Botanical Products
Standard Industrial Classification: SIC 2833
Industry Insider Sentiment Analysis
The Medicinal Chemicals & Botanical Products sector (SIC 2833) acts as a critical barometer for broader economic health. Our real-time monitoring reveals 1788 total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-14 01:33 | 2026-02-13 | CHUC | Charlie's Holdings, Inc. | Stump Ryan | Officer | BUY | $0.20 | 250,000 | $50,000 | 2,351,968 |
| 2026-02-14 01:30 | 2026-02-13 | CHUC | Charlie's Holdings, Inc. | SICIGNANO HENRY III | Officer | BUY | $0.20 | 250,000 | $50,000 | 9,850,001 |
| 2026-02-14 01:25 | 2026-02-13 | CHUC | Charlie's Holdings, Inc. | Montesano Matthew P | Officer | BUY | $0.20 | 100,000 | $20,000 | 2,825,409 |
| 2026-02-14 01:19 | 2026-02-13 | CHUC | Charlie's Holdings, Inc. | King Michael D | Director | BUY | $0.20 | 500,000 | $100,000 | 6,750,001 |
| 2026-02-14 01:12 | 2026-02-13 | CHUC | Charlie's Holdings, Inc. | Carmines Edward | Director | BUY | $0.20 | 250,000 | $50,000 | 2,156,481 |
| 2026-02-13 03:53 | 2026-02-11 | CGC | Canopy Growth Corp | Mongeau Luc | Director, Officer | SELL | $1.06 | 9,376 | $9,951 | 802,992 |
| 2026-01-20 22:07 | 2026-01-15 | AKAN | AKANDA CORP. | HRT FINANCIAL LP | 10% owner | BUY | $1.40 | 29,036 | $40,650 | 15,684 |
| 2026-01-20 22:07 | 2026-01-16 | AKAN | AKANDA CORP. | HRT FINANCIAL LP | 10% owner | SELL | $1.29 | 7,868 | $10,150 | 7,816 |
| 2026-01-03 00:38 | 2025-12-31 | CGC | Canopy Growth Corp | Yanofsky Theresa | Director | SELL | $1.13 | 10,434 | $11,790 | 63,518 |
| 2026-01-03 00:37 | 2025-12-31 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | SELL | $1.13 | 15,715 | $17,758 | 87,672 |
| 2025-12-30 01:46 | 2025-12-26 | CHUC | Charlie's Holdings, Inc. | Carmines Edward | Director | BUY | $0.28 | 100,000 | $27,600 | 100,000 |
| 2025-12-30 01:00 | 2025-12-26 | MNMD | Definium Therapeutics, Inc. | Karlin Daniel | Officer | SELL | $13.15 | 5,600 | $73,623 | 425,025 |
| 2025-12-30 01:00 | 2025-12-26 | MNMD | Definium Therapeutics, Inc. | Barrow Robert | Director, Officer | SELL | $13.15 | 25,791 | $339,072 | 778,477 |
| 2025-12-30 01:00 | 2025-12-26 | MNMD | Definium Therapeutics, Inc. | Sullivan Mark | Officer | SELL | $13.15 | 11,276 | $148,244 | 282,576 |
| 2025-12-18 00:48 | 2025-12-17 | CHUC | Charlie's Holdings, Inc. | SICIGNANO HENRY III | Officer | BUY | $0.21 | 100,000 | $21,000 | 9,600,001 |
| 2025-12-17 00:23 | 2025-12-12 | MRMD | MARIMED INC. | Shaw Timothy | Officer | BUY | $0.11 | 45,455 | $4,868 | 9,236,770 |
| 2025-12-11 19:25 | 2025-12-10 | USNA | USANA HEALTH SCIENCES INC | Mulham David Mulham | Officer | SELL | $21.00 | 873 | $18,333 | 8,387 |
| 2025-12-11 19:21 | 2025-12-10 | USNA | USANA HEALTH SCIENCES INC | Benedict Peter | Officer | SELL | $20.95 | 2,673 | $56,001 | 0 |
| 2025-11-17 16:23 | 2025-11-14 | NAGE | Niagen Bioscience, Inc. | Pamir Ozan | Officer | BUY | $6.82 | 6,685 | $45,617 | 2,220 |
| 2025-11-11 01:20 | 2025-11-10 | USNA | USANA HEALTH SCIENCES INC | Winssinger Frederic J | Director | SELL | $19.21 | 2,000 | $38,420 | 5,986 |
| 2025-11-04 19:28 | 2025-11-03 | USNA | USANA HEALTH SCIENCES INC | FULLER GILBERT A | Director | SELL | $21.48 | 1,057 | $22,704 | 0 |
| 2025-11-03 19:30 | 2025-10-31 | USNA | USANA HEALTH SCIENCES INC | Fleming John Turman | Director | SELL | $19.79 | 1,750 | $34,633 | 4,565 |
| 2025-09-30 23:14 | 2025-09-29 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | SELL | $1.58 | 15,677 | $24,770 | 103,387 |
| 2025-09-30 23:13 | 2025-09-29 | CGC | Canopy Growth Corp | ATKINS M SHAN | Director | SELL | $1.58 | 2,216 | $3,501 | 43,464 |
| 2025-09-30 23:12 | 2025-09-29 | CGC | Canopy Growth Corp | Yanofsky Theresa | Director | SELL | $1.58 | 10,408 | $16,445 | 73,952 |
| 2025-09-30 23:11 | 2025-09-29 | CGC | Canopy Growth Corp | Kruh Willy | Director | SELL | $1.58 | 10,451 | $16,513 | 62,939 |
| 2025-09-27 00:35 | 2025-09-25 | MNMD | Definium Therapeutics, Inc. | Sullivan Mark | Officer | SELL | $9.77 | 11,278 | $110,186 | 293,852 |
| 2025-09-27 00:35 | 2025-09-25 | MNMD | Definium Therapeutics, Inc. | Barrow Robert | Director, Officer | SELL | $9.77 | 25,797 | $252,037 | 804,268 |
| 2025-09-27 00:34 | 2025-09-25 | MNMD | Definium Therapeutics, Inc. | Karlin Daniel | Officer | SELL | $9.77 | 7,704 | $75,268 | 430,625 |
| 2025-09-23 23:15 | 2025-09-22 | CGC | Canopy Growth Corp | Mongeau Luc | Director, Officer | BUY | $1.82 | 27,469 | $49,994 | 812,368 |
| 2025-09-10 00:42 | 2025-09-03 | CHUC | Charlie's Holdings, Inc. | Carmines Edward | Director | BUY | $0.29 | 44,723 | $13,140 | 1,906,481 |
| 2025-08-26 23:15 | 2025-08-22 | CGC | Canopy Growth Corp | Stewart Thomas Carlton | Officer | SELL | $1.74 | 5,768 | $10,036 | 68,203 |
| 2025-08-26 23:15 | 2025-08-22 | CGC | Canopy Growth Corp | Gedeon Christelle | Officer | SELL | $1.74 | 16,929 | $29,456 | 368,488 |
| 2025-08-22 20:11 | 2025-07-19 | HYEX | HEALTHY EXTRACTS INC. | Swanson Donald William | Director, Officer, 10% owner | BUY | $23,536,656.00 | 13,075,920 | $307,763,430,923,520 | 13,075,920 |
| 2025-08-20 23:30 | 2025-08-18 | CGC | Canopy Growth Corp | Gedeon Christelle | Officer | SELL | $1.86 | 4,528 | $8,422 | 385,417 |
| 2025-08-14 00:01 | 2024-11-20 | TRUL | Trulieve Cannabis Corp. | Thronson Susan | Director | BUY | $6.30 | 3,968 | $24,998 | 9,740 |
| 2025-08-13 23:54 | 2024-11-21 | TRUL | Trulieve Cannabis Corp. | May Richard S. | Director | BUY | $6.05 | 1,610 | $9,741 | 551,486 |
| 2025-08-08 21:22 | 2025-08-07 | USNA | USANA HEALTH SCIENCES INC | FULLER GILBERT A | Director | SELL | $29.10 | 1,058 | $30,789 | 0 |
| 2025-08-04 23:06 | 2025-07-31 | TLRY | Tilray Brands, Inc. | Gendel Mitchell | Officer | BUY | $0.58 | 6,000 | $3,496 | 698,287 |
| 2025-07-31 18:03 | 2025-07-30 | USNA | USANA HEALTH SCIENCES INC | Mulham David Mulham | Officer | SELL | $30.26 | 3,515 | $106,364 | 9,260 |
| 2025-07-31 15:31 | 2025-06-11 | SNYR | Synergy CHC Corp. | Ross Jack | Director, Officer, 10% owner | BUY | $2.85 | 27,900 | $79,576 | 410,507 |
| 2025-07-31 01:52 | 2025-07-30 | TLRY | Tilray Brands, Inc. | SIMON IRWIN D | Officer | BUY | $0.61 | 165,000 | $100,106 | 3,941,633 |
| 2025-07-30 22:12 | 2025-07-30 | TLRY | Tilray Brands, Inc. | Merton Carl A | Officer | BUY | $0.60 | 33,500 | $19,939 | 798,069 |
| 2025-07-02 23:16 | 2025-06-30 | CGC | Canopy Growth Corp | Yanofsky Theresa | Director | SELL | $1.23 | 10,425 | $12,823 | 84,360 |
| 2025-07-02 23:16 | 2025-06-30 | CGC | Canopy Growth Corp | Kruh Willy | Director | SELL | $1.23 | 10,468 | $12,876 | 73,390 |
| 2025-07-02 23:15 | 2025-06-30 | CGC | Canopy Growth Corp | Lazzarato David Angelo | Director | SELL | $1.23 | 15,701 | $19,312 | 119,064 |
| 2025-06-26 23:30 | 2025-06-25 | MNMD | Definium Therapeutics, Inc. | Sullivan Mark | Officer | SELL | $6.80 | 11,491 | $78,139 | 305,130 |
| 2025-06-26 23:30 | 2025-06-25 | MNMD | Definium Therapeutics, Inc. | Karlin Daniel | Officer | SELL | $6.80 | 7,848 | $53,366 | 438,329 |
| 2025-06-26 23:30 | 2025-06-25 | MNMD | Definium Therapeutics, Inc. | Barrow Robert | Director, Officer | SELL | $6.80 | 26,491 | $180,139 | 830,065 |
| 2025-06-17 23:05 | 2025-06-16 | CGC | Canopy Growth Corp | Hong Judy Eun Joo | Officer | SELL | $1.63 | 38,678 | $62,867 | 579,889 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Medicinal Chemicals & Botanical Products sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2833) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Medicinal Chemicals & Botanical Products
Every transaction in the Medicinal Chemicals & Botanical Products industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.